These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16671543)

  • 41. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Hayden CA; Fischer ME; Andrews BL; Chilton HC; Turner DD; Walker JH; Tizard IR; Howard JA
    Vaccine; 2015 Jun; 33(25):2881-6. PubMed ID: 25944300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and immune effect of the hepatitis B-BCG combined vaccine for using a needle innoculation.
    Jin L; Wang G; Zhao X; Wang Z; Yang L; Yu A; Xu Y; Li W
    Vaccine; 2010 Aug; 28(37):6041-51. PubMed ID: 20619374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
    Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
    Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
    Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
    J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
    Gupta PN; Khatri K; Goyal AK; Mishra N; Vyas SP
    J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
    Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
    Moon SH; Shin EC; Noh YW; Lim YT
    Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
    He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
    J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-
    Roopngam P; Liu K; Mei L; Zheng Y; Zhu X; Tsai HI; Huang L
    Int J Nanomedicine; 2016; 11():5361-5370. PubMed ID: 27789948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.
    Lugade AA; Bharali DJ; Pradhan V; Elkin G; Mousa SA; Thanavala Y
    Nanomedicine; 2013 Oct; 9(7):923-34. PubMed ID: 23542018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Specific cellular and humoral immune responses induced by intramuscular injection of DNA vaccine containing HBV HBsAg gene in mice].
    Liu S; Tan D; Li C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):313-5. PubMed ID: 12080633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination.
    Chen X; Zhang W; Gao W; Zou Q; Feng C; Liu H; Zhou C; Zhang Y; Wang B
    Viral Immunol; 2012 Aug; 25(4):289-96. PubMed ID: 22876773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis.
    Zhu J; Qin F; Ji Z; Fei W; Tan Z; Hu Y; Zheng C
    AAPS PharmSciTech; 2019 Dec; 21(1):13. PubMed ID: 31807947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
    Dewangan HK; Singh S; Maurya L; Srivastava A
    Curr Drug Deliv; 2018; 15(8):1204-1215. PubMed ID: 29866006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES.
    Kim SJ; Suh D; Park SE; Park JS; Byun HM; Lee C; Lee SY; Kim I; Oh YK
    Virology; 2003 Sep; 314(1):84-91. PubMed ID: 14517062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
    Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
    J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.